These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26489169)

  • 1. Biosimilars Charge the Market But Still Face Many Hurdles.
    Reinke T
    Manag Care; 2015 Apr; 24(4):16-7. PubMed ID: 26489169
    [No Abstract]   [Full Text] [Related]  

  • 2. State laws on biosimilars may drive up plans' costs.
    Carroll J
    Manag Care; 2013 Apr; 22(4):8-9. PubMed ID: 23682380
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosimilars and the European experience: implications for the United States.
    Megerlin F; Lopert R; Taymor K; Trouvin JH
    Health Aff (Millwood); 2013 Oct; 32(10):1803-10. PubMed ID: 24101072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future.
    Grabowski HG; Guha R; Salgado M
    Health Aff (Millwood); 2014 Jun; 33(6):1048-57. PubMed ID: 24889955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparability conundrum: biosimilars in the United States, Europe and Canada.
    Courage N; Parsons A
    Food Drug Law J; 2011; 66(2):203-24, i-ii. PubMed ID: 24505840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Business of biosimilars - 14th annual conference (October 15-17, 2013 - Boston, Massachusetts, USA).
    Bourgoin A
    Drugs Today (Barc); 2013 Dec; 49(12):799-801. PubMed ID: 24524098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Biosimilar Pipeline Seams Seem To Be Bursting.
    Reinke T
    Manag Care; 2017 Mar; 26(3):24-25. PubMed ID: 28510516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarket policy considerations for biosimilar oncology drugs.
    Renwick MJ; Smolina K; Gladstone EJ; Weymann D; Morgan SG
    Lancet Oncol; 2016 Jan; 17(1):e31-8. PubMed ID: 26758759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosimilars battle rages on, Amgen fights both sides.
    Senior M
    Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech innovators jump on biosimilars bandwagon.
    Moran N
    Nat Biotechnol; 2012 Apr; 30(4):297-9. PubMed ID: 22491261
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosimilars.
    Ross A; Richard K
    Conn Med; 2015 May; 79(5):295-9. PubMed ID: 26245019
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosimilars might not measure up to health plan expectations.
    Reinke T
    Manag Care; 2012 Oct; 21(10):12-3. PubMed ID: 23156071
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA sets hierarchy for biosimilars evidence.
    Ratner M
    Nat Biotechnol; 2014 Jul; 32(7):609. PubMed ID: 25004221
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosimilars.
    Bagel J
    J Drugs Dermatol; 2014 Jul; 13(7):788-90. PubMed ID: 25007360
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosimilars take center stage.
    Adams KT
    Manag Care; 2014 Apr; 23(4):44-6. PubMed ID: 24864533
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequestration to slash research grants and delay biosimilars.
    Fox JL
    Nat Biotechnol; 2013 Apr; 31(4):271. PubMed ID: 23563405
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging role of biosimilar epoetins in nephrology in the United States.
    Fishbane S; Shah HH
    Am J Kidney Dis; 2015 Apr; 65(4):537-42. PubMed ID: 25582283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Development. Are trade secrets delaying biosimilars?
    Price WN; Rai AK
    Science; 2015 Apr; 348(6231):188-9. PubMed ID: 25859034
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosimilars Ready, At Last, To Make Their Entrance: Stars Are Born or Do They Fizzle?
    Reinke T
    Manag Care; 2017 Mar; 26(3):20-23. PubMed ID: 28510515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosimilars: a cure to the U.S. health care cost conundrum?
    Hirsch BR; Lyman GH
    Blood Rev; 2014 Nov; 28(6):263-8. PubMed ID: 25260225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.